Salarius Update

RNS Number : 5074B
Tekcapital plc
14 February 2022
 


 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

14 February 2022

Tekcapital Plc

("Tekcapital", the "Company" or "the Group")

 

Portfolio Company Update: Salarius, Ltd. ("Salarius")

Update on MicroSalt and SaltMe! Snacks - Bulk MicroSalt order received from FXM

 

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products from investing in university technology that can improve people's lives, is please to provide an update on MicroSalt, Inc., the U.S. operating subsidiary of Salarius, Ltd.

 

MicroSalt continues its expansion in the low salt and low sodium markets and is pleased to announce that it has executed its first bulk MicroSalt® order through FXM, our Mexican based distribution partner ( see announcement dated 24 September 2020 ). "This order is a testament to the timeliness of our products and our ability to customize our production for the Mexican market" said Rick Guiney, MicroSalt's CEO.

 

"This follows on the heels of the placement of MicroSalt's SaltMe® brand of low sodium potato chips into over 1,350 retail stores nationwide, to-date. We are also pleased to report sales of MicroSalts's SaltMe Chips reflect significant growth to $125,000. in January 2022 vs. $3,000. for January 2021, an approximately 40-fold increase. Whilst it's too early to place a firm number of estimated revenues for our chips in 2022 we believe that we may see significant sales growth in the current year," said Guiney.

"The health issues surrounding the excess consumption of sodium cannot be overstated and the ever-increasing profile of low salt and sodium products serves not only as a launching pad for MicroSalt but acts as a foundational tool in our fight to improve the health and wellness of our family, friends, neighbors and the world." Said Guiney

MicroSalt is a subsidiary of portfolio company, Salarius. MicroSalt aims to revolutionize the food industry with its patented sodium microparticle, that delivers the full-flavour experience of salt with roughly half the sodium. MicroSalt® is all-natural, non-GMO, and Kosher.

 

About Salarius Ltd.

Salarius, is the developer and manufacturer of a proprietary low-sodium salt called MicroSalt®. We are passionate about improving peoples' lives with better-for-you snacks by taking the lead in the industry by providing the best low-sodium salt solution, based on the mechanical transformation of the salt particle itself. This solution is the only one that delivers real salt flavor because it is salt. Our new patented technology produces salt crystals that are approximately one hundred times smaller than typical table salt, delivering a powerful saltiness as the micro-grains dissolve in the mouth, with approximately 50% less sodium consumption.

 

Additionally, the ultra-small particle size enhances product adhesion, which reduces waste and provides improved flavor consistency. MicroSalt® and SaltMe® are registered trademarks of MicroSalt Inc.

 

To learn more about MicroSalt please visit https://Salarius.co /.  

To learn more about SaltMe! snacks please visit   https://saltme.com/ .

 

Tekcapital owns 97.2% of the share capital of Salarius Ltd. and approximately 80% of the share capital of MicroSalt Inc., its U.S. subsidiary.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com .

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

Tekcapital Plc  


Via Flagstaff IR

Clifford M. Gross, Ph.D. 






SP Angel  Corporate Finance LLP  (Nominated Adviser and Broker)


+44 (0) 20 3470 0470  

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

 



 

Flagstaff Strategic and Investor Communications     +44 (0)207 129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon 

 

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Salarius that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Salarius' and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Salarius or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither Salarius nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDTJMRTMTMBBRT

Companies

Tekcapital (TEK)
UK 100

Latest directors dealings